Workshop 19
From molecular mechanism to therapeutic strategies in enteric infections (FG GI/FG PW)

Programme

• 09:00 – 09:15 10 Min. 5 Min.

  • Vortrag
  • GIPWV 104

  Serotype-specific mutation in the virulence factor EspL identifies amino acid residue essential for EPEC-mediated RHIM protein cleavage

  • Sabrina Mühlen (Bochum, DE)

   Gastrointestinal infections (FG GI/FG PW)
• 09:15 – 09:30 10 Min. 5 Min.

  • Vortrag
  • GIPWV 105

  Innate activation of human neutrophils and neutrophil-like cells by the proinflammatory bacterial metabolite ADP-heptose and Helicobacter pylori

  • Larissa Faass (München, DE)
  • Christine Josenhans (München, DE)

   Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)
• 09:30 – 09:45 10 Min. 5 Min.

  • Vortrag
  • GIPWV 106

  High copper supplementation in piglets as a habitat filtering factor aiding colonization resistance of post-weaning microbiome

  • Rafał Kolenda (Norwich, GB)

   Microbe-microbe interactions; Commensal-host interactions; Clinical microbiome research; Microbiome and infections (FG PW)
• 09:45 – 10:00 10 Min. 5 Min.

  • Vortrag
  • GIPWV 107

  Polysaccharides as promising targets for vaccination against Clostridioides (C.) difficile infection

  • Jochen Mattner (Erlangen, DE)

   Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)
• 10:00 – 10:15 10 Min. 5 Min.

  • Vortrag
  • GIPWV 108

  Development of anti-virulence agents targeting HilD, the central regulator of Salmonella pathogenicity

  • Samuel Wagner (Tübingen, DE)

   Mikrobielle Pathogenität (FG GI/FG MP/jDGHM)